Elie Matar

Profile

Dr Elie Matar

Elie is a dual-trained neurologist and sleep physician at Royal Prince Alfred Hospital and a translational clinician-scientist at the University of Sydney, supported by an NHMRC Emerging Leadership Fellowship and a Horizon Fellowship. He has obtained subspecialty expertise in movement disorders, cognitive neurology, and sleep through clinical fellowships and visitorships at the National Hospital for Neurology and Neurosurgery (London, UK) and the Mayo Clinic (Rochester, US).

Dr Matar leads a multidisciplinary research program investigating the phenomenology, pathophysiology, and progression of synuclein-based diseases, with a particular focus on REM sleep behaviour disorder and dementia with Lewy bodies, and the role of sleep disturbance and delirium in disease evolution. His work spans neuroimaging, sleep neurophysiology, neuropathology, actigraphy, clinical phenotyping, and clinical trials, supported by more than $6 million in competitive grant funding. He is the founder of the ANZAN Sleep Interest Group, an executive member of the Movement Disorders Society Asian and Oceanic Section and serves on the Australasian Cognitive Neurology Association executive. Dr Matar is internationally regarded as a leading authority on prodromal Lewy body disorders and their sleep–wake manifestations.

Elie is a dual-trained neurologist and sleep physician at Royal Prince Alfred Hospital and a translational clinician-scientist at the University of Sydney, supported by an NHMRC Emerging Leadership Fellowship and a Horizon Fellowship. He has obtained subspecialty expertise in movement disorders, cognitive neurology, and sleep through clinical fellowships and visitorships at the National Hospital for Neurology and Neurosurgery (London, UK) and the Mayo Clinic (Rochester, US).

Dr Matar leads a multidisciplinary research program investigating the phenomenology, pathophysiology, and progression of synuclein-based diseases, with a particular focus on REM sleep behaviour disorder and dementia with Lewy bodies, and the role of sleep disturbance and delirium in disease evolution. His work spans neuroimaging, sleep neurophysiology, neuropathology, actigraphy, clinical phenotyping, and clinical trials, supported by more than $6 million in competitive grant funding. He is the founder of the ANZAN Sleep Interest Group, an executive member of the Movement Disorders Society Asian and Oceanic Section and serves on the Australasian Cognitive Neurology Association executive. Dr Matar is internationally regarded as a leading authority on prodromal Lewy body disorders and their sleep–wake manifestations.

Last updated 23 September 2025